Citigroup’s Caribou Biosciences CRBU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $39.5K | Sell |
31,361
-32,558
| -51% | -$41K | ﹤0.01% | 4154 |
|
|
2025
Q1 | $58.4K | Sell |
63,919
-11,856
| -16% | -$10.8K | ﹤0.01% | 4068 |
|
|
2024
Q4 | $120K | Buy |
75,775
+4,400
| +6% | +$7K | ﹤0.01% | 3902 |
|
|
2024
Q3 | $140K | Buy |
71,375
+18,784
| +36% | +$36.8K | ﹤0.01% | 3824 |
|
|
2024
Q2 | $86.2K | Sell |
52,591
-416,929
| -89% | -$684K | ﹤0.01% | 3559 |
|
|
2024
Q1 | $2.41M | Buy |
469,520
+307,801
| +190% | +$1.58M | ﹤0.01% | 1705 |
|
|
2023
Q4 | $927K | Sell |
161,719
-59,447
| -27% | -$341K | ﹤0.01% | 2213 |
|
|
2023
Q3 | $1.06M | Buy |
221,166
+194,816
| +739% | +$931K | ﹤0.01% | 1868 |
|
|
2023
Q2 | $112K | Sell |
26,350
-169,345
| -87% | -$720K | ﹤0.01% | 3522 |
|
|
2023
Q1 | $1.04M | Buy |
195,695
+92,587
| +90% | +$492K | ﹤0.01% | 1978 |
|
|
2022
Q4 | $648K | Sell |
103,108
-25,516
| -20% | -$160K | ﹤0.01% | 2360 |
|
|
2022
Q3 | $1.36M | Buy |
128,624
+114,599
| +817% | +$1.21M | ﹤0.01% | 1886 |
|
|
2022
Q2 | $76K | Sell |
14,025
-8,464
| -38% | -$45.9K | ﹤0.01% | 3676 |
|
|
2022
Q1 | $206K | Sell |
22,489
-8,007
| -26% | -$73.3K | ﹤0.01% | 3386 |
|
|
2021
Q4 | $460K | Buy |
30,496
+28,271
| +1,271% | +$426K | ﹤0.01% | 3126 |
|
|
2021
Q3 | $53K | Buy |
+2,225
| New | +$53K | ﹤0.01% | 3964 |
|